Zavesca is used in patients who cannot receive the standard treatment of enzyme replacement therapy (ERT) given by infusion (drip into a vein);  adults, adolescents and children with Niemann-Pick type C disease, a potentially fatal disease in which glycosphingolipids build up within cells in the brain and elsewhere in the body.